Código QR

Magnitude and Determinants of Weight Loss Response to GLP-1/GIP Receptor Agonists in India: A Real-World Time-to-Event Analysis

Introduction: Obesity and type 2 diabetes (T2D) are rapidly increasing in India. Although newer glucagon-like peptide/glucose-dependent insulinotropic polypeptide (GLP-1/GIP) receptor agonists have demonstrated considerable efficacy in weight loss, real-world evidence from the Indian population is l...

ver descrição completa

Na minha lista:
Principais autores: Godana Jarso, Shama Mahendru, Aditya Dutta, Rutuja Sharma, Abebe Megerso, Ambrish Mithal
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Medknow Publications 2026-03-01
Colecção:Indian Journal of Endocrinology and Metabolism
Assuntos:
diabetes
glp1/gip receptor agonists
obesity
semaglutide
tirzepatide
weight loss
Acesso em linha:https://journals.lww.com/10.4103/ijem.ijem_1085_25
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados